2511 — HighTide Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- HK$666.68m
- -HK$106.12m
Annual cashflow statement for HighTide Therapeutics, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -221 | -190 | -939 |
| Depreciation | |||
| Non-Cash Items | 116 | -8.21 | 592 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 13.3 | 24.8 | -12.9 |
| Change in Prepaid Expenses | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -90.5 | -172 | -358 |
| Capital Expenditures | -1.75 | -0.183 | -0.801 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | 3.33 | -415 | 317 |
| Sale of Fixed Assets | |||
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | 1.59 | -416 | 317 |
| Financing Cash Flow Items | -18.4 | -1.25 | 114 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 494 | 46 | 361 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 398 | -492 | 335 |